-
The Internet age has brought all kinds of conveniences and apps for your smart phone, from the popular app GRINDR (allowing you a speedy hookup with the nearest sexually available individual) to the newest MedXSafe, which allows you to literally bump phones and share confidential STD and HIV info before you bump into bed.
-
The ECG shown above was obtained from a 62-year-old man who presented to the emergency department with a history of several presyncopal episodes in recent months. His ECG was diagnosed as showing acute anterior ST elevation myocardial infarction (STEMI). Do you agree? What treatment is indicated?
-
Calcium supplementation in women; type 2 diabetes treatments and pancreatitis risk; treating chronic idiopathic urticaria; rivaroxaban and VTE; and FDA actions.
-
An oral multikinase inhibitor has been approved by the FDA for treatment of metastatic colorectal cancer as well as advanced gastrointestinal stromal tumors (GIST). Regorafenib is marketed by Bayer HealthCare Pharmaceuticals as Stivarga.
-
-
Special Subgroups in Hypertension: Obese Hypertensives; Selection Criteria for Lung Cancer Screening; Extended Treatment of VTE with Dabigatran vs Warfarin
-
-
Borderline personality disorder (BPD) is a striking personality dysfunction characterized by inherent difficulties with self-regulation as well as chronic self-destructive behavior. In patients with this disorder, the pain experience is seemingly paradoxical. During acute self-destructive acts, up to 80% of individuals with BPD describe attenuated responses to pain (i.e., high tolerance of pain).
-
Gabapentin for Chronic Cough; Can Statins Reduce Cancer-Related Mortality?; Are All of Those Multivitamin Dollars Well Spent?
-
The FDA has approved the first in class α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptor antagonist for the treatment of seizures. Perampanel is an orally active noncompetitive AMPA antagonist. The drug is marketed by Eisai Inc. as Fycompa.
